Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”On 17 November, I had the pleasure of taking part in the EAS Lipoprotein(a) Workshop, organized by the European Atherosclerosis Society with the support of Novartis and Fondazione SISA.
It was a highly stimulating opportunity to share experiences on the role of Lp(a) in cardiovascular risk and to further strengthen collaboration within the Lp(a)CCELERATE study.
I left the meeting with clearer ideas, fresh perspectives and – above all – the feeling of being part of a community of colleagues genuinely committed to improving CvPrev
Many thanks to the organizers and to all participants for their questions, insights and openness in building the next steps of this journey together.”
Stay updated with Hemostasis Today.
-
Jan 14, 2026, 11:38Khokon Miah Akanda Shares A major 4-Guideline Comparison on BP Management in Stroke
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription